Tinea Nigra Clinical Presentation

  • Author: Robert A Schwartz, MD, MPH; Chief Editor: William D James, MD   more...
 
Updated: Apr 20, 2012
 

History

Generally, patients with tinea nigra are asymptomatic. Rarely, pruritus may be reported. The absence of any discomfort often delays the patient's decision to seek medical advice.

Patients who live in the inland areas of the United States generally report a history of foreign travel, most often to the Caribbean islands. In addition, patients may have acquired this infection while visiting the tropical regions of Asia or Africa. Those who reside in the coastal regions do not necessarily report any travel outside of the United States.

Uezato et al[10] reported a case of tinea nigra palmaris from Okinawa, Japan on the left palm of a 13-year-old girl, who had noticed the pigmented, asymptomatic macule on her left palm approximately 4-5 years prior to presentation. She stated the lesion became lighter after a bath and darkened some time later. Physical examination revealed a 4 X 5-cm, dark brown, and irregularly shaped macule.

Histological findings were reported as follows: "Direct potassium hydroxide (KOH) microscopic examination from skin scrapings revealed branched brown hyphae with light brown septa. A fungal culture on Sabouraud's agar media produced wet, medium brown, yeast-like colonies, the surface of which later became black and shiny. A slide culture disclosed light brown, elliptic or peanut-shaped conidia comprised of one to two ampullaceous cells. Scanning electron microscopic examination of the conidia showed both annellation [sic] conidia with lunate bud scars and sympodial conidiogenesis."

DNA was extracted from separately cultured fungi, and polymerase chain reaction with primers specific to H werneckii was performed; results showed positive bands. Direct sequencing was performed with the DNA segments from the positive bands. Type C H werneckii was determined to be the causative fungus, based on the base sequences obtained, and tinea nigra due to H werneckii was diagnosed.

Next

Physical

Tinea nigra is characterized by the presence of a painless brown-to-black macule, as shown in the image below. The macule appears insidiously as a small dark spot.

Tinea nigra, evident as a painless cluster of browTinea nigra, evident as a painless cluster of brown-to-black macules. Courtesy of Dr. Peter Santalucia.

Hyperpigmentation of the macule ranges from light brown to black discoloration, resembling silver nitrate or India ink stains. The borders are typically discrete. The pigmentary change may appear mottled or velvety.

The lesions are typically solitary, although more than one lesion can be present. Solitary lesions are typically located on the palmar surfaces of the hands or plantar surfaces of the feet, and they may extend to the fingers or toes, respectively. Other areas of the body, such as the neck and chest wall, are more rarely affected.

The shape of the lesion varies, and they may appear ovoid, round, or irregular. The lesion slowly grows over weeks to months. The size may range from a few millimeters to several centimeters in diameter, depending on the duration of the infection.

Other physical findings, such as erythema or induration, are absent. Rarely, scaling is present. Dermoscopic examination may facilitate the in vivo diagnosis of tinea nigra.[11] Manual and digital dermatoscopic images show irregularly distributed dark brown-pigmented dots with a filamentous aspect.[12]

Although tinea nigra is often easily diagnosed on clinical grounds alone,[13] the use of dermoscopy for palmar or plantar pigmentation may enhance the recognition of tinea nigra.[14] Characteristic features evident on dermoscopy are superficial fine, wispy, light-brown strands forming a reticularlike patch with a uniform brown color. These strands do not follow the furrows and ridges normally observed in this skin.

Previous
Next

Causes

Tinea nigra is due to infection by the fungus, P werneckii, which is classified in the family Dematiaceae, class Hyphomycetes, phylum Deuteromycota. Infection occurs after inoculation subsequent to trauma. The dermatomycosis tends to occur in areas with an increased concentration of eccrine sweat glands. Hyperhidrosis appears to be a risk factor for this disease.

Previous
 
 
Contributor Information and Disclosures
Author

Robert A Schwartz, MD, MPH  Professor and Head, Dermatology, Professor of Pathology, Pediatrics, Medicine, and Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey-New Jersey Medical School

Robert A Schwartz, MD, MPH is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American College of Physicians, and Sigma Xi

Disclosure: Nothing to disclose.

Coauthor(s)

George Kihiczak, MD  Clinical Associate Professor, Department of Dermatology, New Jersey Medical School and University Hospital

George Kihiczak, MD is a member of the following medical societies: American Academy of Dermatology, American Medical Association, and Medical Society of New Jersey

Disclosure: Nothing to disclose.

Specialty Editor Board

Neil Shear, MD  Professor and Chief of Dermatology, Professor of Medicine, Pediatrics and Pharmacology, University of Toronto Faculty of Medicine; Head of Dermatology, Sunnybrook Women's College Health Sciences Center and Women's College Hospital, Canada

Neil Shear, MD is a member of the following medical societies: American Academy of Dermatology, American Society for Clinical Pharmacology and Therapeutics, Canadian Dermatology Association, Canadian Medical Association, Ontario Medical Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Paul Krusinski, MD  Director of Dermatology, Fletcher Allen Health Care; Professor, Department of Internal Medicine, University of Vermont College of Medicine

Paul Krusinski, MD is a member of the following medical societies: American Academy of Dermatology, American College of Physicians, and Society for Investigative Dermatology

Disclosure: Nothing to disclose.

Catherine M Quirk, MD  Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania

Catherine M Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD  Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology

Disclosure: Elsevier Royalty Other

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author, Vinay Arya, MD, to the development and writing of this article.

References
  1. Schwartz RA. Superficial fungal infections. Lancet. Sep 25-Oct 1 2004;364(9440):1173-82. [Medline].

  2. Perez C, Colella MT, Olaizola C, Hartung de Capriles C, Magaldi S, Mata-Essayag S. Tinea nigra: report of twelve cases in Venezuela. Mycopathologia. Oct 2005;160(3):235-8. [Medline].

  3. Badali H, Carvalho VO, Vicente V, et al. Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol. Feb 2009;47(1):51-62. [Medline].

  4. Blank H. Tinea nigra: a twenty-year incubation period?. J Am Acad Dermatol. Jul 1979;1(1):49-51. [Medline].

  5. Lenassi M, Vaupotic T, Gunde-Cimerman N, Plemenitas A. The MAP kinase HwHog1 from the halophilic black yeast Hortaea werneckii: coping with stresses in solar salterns. Saline Systems. 2007;3:3. [Medline].

  6. Rezusta A, Gilaberte Y, Betran A, Gene J, Querol I, Arias M, et al. Tinea nigra: a rare imported infection. J Eur Acad Dermatol Venereol. Jan 2010;24(1):89-91. [Medline].

  7. Chen GY, Cheng YW, Wang CY, Hsu TJ, Hsu MM, Yang PT, et al. Prevalence of skin diseases among schoolchildren in Magong, Penghu, Taiwan: a community-based clinical survey. J Formos Med Assoc. Jan 2008;107(1):21-9. [Medline].

  8. Hall J, Perry VE. Tinea nigra palmaris: differentiation from malignant melanoma or junctional nevi. Cutis. Jul 1998;62(1):45-6. [Medline].

  9. Tseng SS, Whittier S, Miller SR, Zalar GL. Bilateral tinea nigra plantaris and tinea nigra plantaris mimicking melanoma. Cutis. Oct 1999;64(4):265-8. [Medline].

  10. Uezato H, Gushi M, Hagiwara K, Kayo S, Hosokawa A, Nonaka S. A case of tinea nigra palmaris in Okinawa, Japan. J Dermatol. Jan 2006;33(1):23-9. [Medline].

  11. Zalaudek I, Giacomel J, Cabo H, Di Stefani A, Ferrara G, Hofmann-Wellenhof R, et al. Entodermoscopy: a new tool for diagnosing skin infections and infestations. Dermatology. 2008;216(1):14-23. [Medline].

  12. Paschoal FM, de Barros JA, de Barros DP, de Barros JC, Filho CD. Study of the dermatoscopic pattern of tinea nigra: report of 6 cases. Skinmed. Nov-Dec 2010;8(6):319-21. [Medline].

  13. Muir J. Tinea nigra and dermoscopy. Australas J Dermatol. Feb 2012;53(1):e14; author reply e15. [Medline].

  14. Piliouras P, Allison S, Rosendahl C, Buettner PG, Weedon D. Dermoscopy improves diagnosis of tinea nigra: a study of 50 cases. Australas J Dermatol. Aug 2011;52(3):191-4. [Medline].

  15. Tilak R, Singh S, Prakash P, Singh DP, Gulati AK. A case report of tinea nigra from North India. Indian J Dermatol Venereol Leprol. Sep-Oct 2009;75(5):538-9. [Medline].

  16. Rossetto AL, Cruz RC. Spontaneous cure in a case of Tinea nigra. An Bras Dermatol. Feb 2012;87(1):160-2. [Medline].

  17. Burke WA. Tinea nigra: treatment with topical ketoconazole. Cutis. Oct 1993;52(4):209-11. [Medline].

  18. Marks JG Jr, King RD, Davis BM. Treatment of tinea nigra palmaris with miconazole. Arch Dermatol. Mar 1980;116(3):321-2. [Medline].

  19. Shannon PL, Ramos-Caro FA, Cosgrove BF, Flowers FP. Treatment of tinea nigra with terbinafine. Cutis. Sep 1999;64(3):199-201. [Medline].

  20. Babel DE, Pelachyk JM, Hurley JP. Tinea nigra masquerading as acral lentiginous melanoma. J Dermatol Surg Oncol. May 1986;12(5):502-4. [Medline].

Previous
Next
 
Tinea nigra, evident as a painless cluster of brown-to-black macules. Courtesy of Dr. Peter Santalucia.
Tinea nigra, showing hyperkeratosis and mild acanthosis. A scant amount of perivascular lymphocytic infiltrate may be found in the papillary and subpapillary layers of the dermis (hematoxylin and eosin stain). Courtesy of Thomas N. Helm, MD.
Tinea nigra, with histologic section demonstrating periodic acid-Schiff–positive septate hyphae within the stratum corneum. Courtesy of Thomas N. Helm, MD.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.